PATHOLOGY, ONCOPHARMACY AND RADIODIAGNOSTIC
[CODE NO. 3905]
The private-sector provision of health services is quite large and growing in many low- and middle-income countries. Recognition of the importance of private-sector health care providers has led to the formation of several international working groups, forums, and technical assistance projects in recent years. Their discussions, however, have predominantly focused on provision of clinical health care by private-sector providers. Very little knowledge exists regarding the provision of diagnostic services by the private sector in developing countries in terms of market structure, size, and services being offered.
Through decades of work on diagnostics technology development, PATH is cognizant of the difficulty of introducing new diagnostic technologies and then attaining wide-scale use of them in low-income countries. In the past, PATH has primarily focused on delivering new technologies by using public-sector channels and did not fully exploit other types of service delivery models. In recent years, private-sector service delivery models have emerged in lowand middle-income countries and can be used for delivery of new diagnostic technologies.
COST ESTIMATION
Plant Capacity PATHOLOGY, ONCOPHARMACY AND RADIODIAGNOSTIC
Land & Building (14200 sq.mt.) Rs. 6.00 Cr
Plant & Machinery Rs.7.13 Cr
Working Capital for 2 Months Rs.3.47 Cr
Total Capital Investment Rs.17.07 Cr
Rate of Return 26%
Break Even Point 53%
INTRODUCTION
MOST COMMONLY USED DIAGNOSTIC MACHINES ARE
SPECIALIZED MEDICAL ELECTRONIC INSTRUMENTS LIKE
ANALYTICAL EQUIPMENT FOR PATHOLOGICAL AND BIO-CHEMICAL DIAGNOSIS WHICH ARE CURRENTLY BEING MANUFACTURED AND
MARKETED BY UNITS INCLUDE
SIGNIFICANCE OF ELECTRONICS IN MODERN MEDICAL
DIAGNOSTIC INSTRUMENTS
SETTING UP A DIAGNOSTIC LAB IN INDIA
SPACE
FINANCE
INSTRUMENTS
STAFF
LICENSE/ REGISTRATION
MEDICAL KNOWLEDGE
RADIOLOGY MARKET IN INDIA
OPPORTUNITIES IN ONCOLOGY DRUGS MARKET
TREND IN INDIAN CANCER MARKET
GROWTH IN DIAGNOSTIC LAB
OPTIMISTIC GROWTH
CHANGING DYNAMICS
PRICING PRESSURES AND ITS IMPACT
CONSOLIDATION AND INTEGRATION TO BUILD A BETTER BUSINESS
ENVIRONMENT
BEING FUTURE READY
MARKET OVERVIEW IN DIAGNOSTIC SECTOR
REGULATORY CHALLENGES TROUBLING DIAGNOSTIC GROWTH PATH
THE PENDING STATE OF THE CLINICAL ESTABLISHMENT ACT
THE INDIAN DIAGNOSTICS AND MEDICAL DEVICES INDUSTRIES
ON THE GROWTH PATH
MODEL DESCRIPTION: HUB AND SPOKE EXPANSION
DRIVERS
CHALLENGES
OPPORTUNITIES IN THE DIAGNOSTICS LABORATORY
BENEFITS OF CRM IN THE DIAGNOSTICS SECTOR
SURGING AHEAD
SCENARIO OF HEALTHCARE IN INDIA
FIGURE: HEALTHCARE PYRAMID
FIGURE: PRIMARY CARE
FIGURE: DISTRIBUTION OF DEATHS BY MAJOR CAUSE, INDIA (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA)
FIGURE: CAUSES OF DEATH IN URBAN AREAS (25 – 69 YRS. OF AGE AS %) CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA) 62
FIGURE: CAUSES OF DEATH IN RURAL AREAS (25 – 69 YRS. OF AGE AS %) CARDIOVASCULAR DISEASES CONSTITUTE THE LARGEST SEGMENT (SOURCE: SPECIAL SURVEY OF DEATHS, REGISTRAR GENERAL OF INDIA) 63
HEALTH CARE FINANCING IN INDIA
FIGURE: OUT OF-POCKET SPENDING IS THE BIGGEST SOURCE
OF FINANCING HEALTHCARE DUE TO LOW INSURANCE COVER.
FIGURE: MODES OF FINANCING HEALTHCARE IN INDIA
GOVERNMENT INCENTIVES ON DIAGNOSTICS:
INDIA ENTRY – KEY CHECK POINTS
NEED FOR LOCALIZATION
PRODUCT FOR ONCOLOGY
INJECTIONS
TABLETS
CAPSULES
PRICE RANGE OF ONCOLOGY DRUGS
PRICE RANGE OF ONCOLOGY DRUG ACCORDING TO CATEGORY IN INDIA
ONCOLOGY DRUGS AND ITS PREVAILING PACKAGING
ONCOLOGY PHARMA COMPANIES IN INDIA
PROFILES OF EXISTING DIAGNOSTIC LABORATORIES
PRESENTLY RUNNING FEW OUT OF MANY DIAGNOSTIC LABS
DETAILS OF DIAGNOSTICS AND MEDICAL EQUIPMENTS
ELECTROCARDIOGRAPHS
THERE ARE OTHER COMPONENTS TO THE ELECTROCARDIOGRAPH:
THEORY OF ELECTROCARDIOGRAPHY
QRS IS UPRIGHT IN A LEAD WHEN ITS AXIS IS ALIGNED WITH
THAT LEAD'S VECTOR
SCHEMATIC REPRESENTATION OF NORMAL ECG
ELECTROCARDIOGRAM GRID
SONOGRAPHY INSTRUMENTS
FROM SOUND TO IMAGE
PRODUCING A SOUND WAVE
RECEIVING THE ECHOES
FORMING THE IMAGE
DISPLAYING THE IMAGE
SOUND IN THE BODY
X-RAY MACHINE
MEDICAL ULTRASOUND
ELECTRO CARDIOGRAPH (ECG)
B.P. CHECK-UP
BLOOD TEST
URELOGICAL TEST
STOOL TEST
SUGAR TEST FOR DIABETIC PATIENTS
SEMEN TEST
MEDICAL IMAGING
ULTRASOUND IMAGING
COMPUTERISED TOMOGRAPHY (CT)
MAGNETIC RESONANCE IMAGING (MRI)
POSITRON EMISSION TOMOGRAPHY (PET)
MAGNETIC SOURCE IMAGING (MSI)
APPLICATIONS
MANUFACTURERS/SUPPLIERS OF ONCOLOGY DRUGS
ADDRESSES OF DIAGNOSTIC CONSUMABLES SUPPLIERS
ADDRESSES OF DIAGNOSTIC EQUIPMENT & INSTRUMENT SUPPLIERS
X-RAW MACHINE
ULTRASOUND MACHINE
EEG MACHINES
APPENDIX – A:
01. PLANT ECONOMICS
02. LAND & BUILDING
03. PLANT AND MACHINERY
04. OTHER FIXED ASSESTS
05. FIXED CAPITAL
06. RAW MATERIAL
07. SALARY AND WAGES
08. UTILITIES AND OVERHEADS
09. TOTAL WORKING CAPITAL
10. TOTAL CAPITAL INVESTMENT
11. COST OF PRODUCTION
12. TURN OVER/ANNUM
13. BREAK EVEN POINT
14. RESOURCES FOR FINANCE
15. INSTALMENT PAYABLE IN 5 YEARS
16. DEPRECIATION CHART FOR 5 YEARS
17. PROFIT ANALYSIS FOR 5 YEARS
18. PROJECTED BALANCE SHEET FOR (5 YEARS)
